- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT01647997
Lactate Metabolism After an Endotoxin Challenge in Healthy Humans
Effects of an Acute Administration of Bacterial Endotoxin on Whole Body and Regional Lactate Metabolism in Healthy Male Volunteers
Sepsis is characterized by hyperlactatemia, the severity of which is proportionate with sepsis severity. The pathophysiological mechanisms (increased lactate production vs decreased lactate utilization; tissues involved in sepsis-induced lactate production) remain largely unknown.
In this study, the investigators will assess whole body and regional metabolism in healthy young male subjects on two occasions, once after administration of an intravenous bacterial endotoxin challenge, and once without intervention.
In one group of subjects, whole body lactate metabolism will be measured over 10 hours after the endotoxin challenge
- Energy expenditure and net substrate oxidation rates (indirect calorimetry)
- Lactate kinetics (measured by means of a continuous, exogenous sodium lactate infusion)
- Glucose kinetics (measured with 6,6 d2 glucose)
- Hemodynamic parameters and body temperature
- Blood clinical chemistry In one group of subjects, whole body lactate metabolism will be measured over 10 hours after the endotoxin challenge
- Energy expenditure and net substrate oxidation rates (indirect calorimetry)
- Lactate kinetics (measured by means of a continuous, exogenous sodium lactate infusion)
- Glucose kinetics (measured with 6,6 d2 glucose)
- Hemodynamic parameters and body temperature
- Blood clinical chemistry
In a second group of subjects, regional muscle lactate metabolism will be measured over 10 hours after the endotoxin challenge by means of muscle microdialysis
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Vaud
-
Lausanne, Vaud, Suisse, CH-1011
- Centre Hospitalier Universitaire Vaudois
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- gender male
- body mass index (BMI) < 25 kg/m2
- absence of known disease
Exclusion Criteria:
- any known pathology
- abnormal cardio-pulmonary and hemodynamic status
- electrocardiographic alterations
- history of allergy
- current medications
- drug abuse
- consumption of more than 20g/day alcohol
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Science basique
- Répartition: Randomisé
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Expérimental: study 1a
whole body lactate production after bacterial endotoxin challenge
|
iv administration of 2ng/kg bacterial endotoxin
|
Aucune intervention: study 1b
basal whole body lactate production
|
|
Expérimental: study 2a
muscle lactate concentration after bacterial endotoxin challenge
|
iv administration of 2ng/kg bacterial endotoxin
|
Aucune intervention: study 2b
basal muscle lactate concentrations
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Whole body lactate production
Délai: single bacterial endotoxin administration; measurements over 6.5 hours following administration
|
Whole body lactate clearance will be measured by measuring the increase in blood lactate at steady state during a conrtinuous exogenous sodium lactate infusion. Lactate production will be calculated as the product of lactate clearance times per-infusion blood lactate concentration |
single bacterial endotoxin administration; measurements over 6.5 hours following administration
|
skeletal muscle lactate concentration
Délai: single bacterial endotoxin administration; measurements over 6.5 hours following administration
|
interstitial muscle measured by means of in vivo microdialysis ; calculation of muscle-blood lactate gradient
|
single bacterial endotoxin administration; measurements over 6.5 hours following administration
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
whole body energy expenditure
Délai: single bacterial endotoxin administration; measurements over 6.5 hours following administration
|
open circuit indirect calorimetry (hood)
|
single bacterial endotoxin administration; measurements over 6.5 hours following administration
|
body temperature
Délai: single bacterial endotoxin administration; measurements over 6.5 hours following administration
|
single bacterial endotoxin administration; measurements over 6.5 hours following administration
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: René Chiolero, MD, Centre Hospitalier Universitaire Vaudois
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- Lsne-128/01
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .